After CCl4 injection-induced liver fibrosis, TGF-β1 expression followed a similar pattern, rising for 3 days before declining on Day 5, which was associated with the pattern of ALT and AST levels, which peaked on Days 1 and 3 and then decreased on Day 5114. The gene discussed is TGFB1; the disease is Hepatic fibrosis.